Get the Stockscreener App
10.16
0.20%
0.02
Drugs Made In America Acquisition Corp stock is traded at $10.16, with a volume of 277.
It is up +0.20% in the last 24 hours and up +0.49% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.14
Open:
$10.16
24h Volume:
277
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.20%
1M Performance:
+0.49%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.16
$10.16
1-Week Range:
$10.13
$10.16
52-Week Range:
$10.00
$10.82
Drugs Made In America Acquisition Corp Stock (DMAAU) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
954-870-3104
Address
2 PELICAN DR., FORT LAUDERDALE
Compare DMAAU with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAAU
Drugs Made In America Acquisition Corp
|
10.16 | 0 | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.53 | 1.80B | 3.13B | 50.80M | 555.00M | 0.1772 |
|
AACT
Ares Acquisition Corporation Ii
|
11.22 | 697.50M | 0 | 16.92M | -1.35M | 0.29 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.67 | 460.58M | 0 | 1.30M | 0 | 0.0301 |
|
AAM
Aa Mission Acquisition Corp
|
10.27 | 452.93M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.09 | 450.63M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Stock (DMAAU) Latest News
ICR, the Leading SPAC Communications and Advisory Firm, Publishes its Q1 2025 SPAC Market Update & Outlook - Business Wire
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Pfizer Inc. - Britannica
AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica
Theratechnologies’ stock soars on disclosure of acquisition offer by U.S. company - Montreal Gazette
'I bought their dream': How a US company's huge land deal in Senegal went bust - Yahoo
Drugs Made In America Acquisition Corp. (DMAA) reports earnings - qz.com
Bright Green Unveils Massive $2B Cannabis Strategy with Zero Shareholder Dilution - StockTitan
Bright Green Corporation Announces the next steps for the completion of its restructuring plan - The Manila Times
DRUGS MADE IN AMERICA ACQUISITION CORP- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
India-based Syngene acquires its first US biologics site - Manufacturing Dive
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger - Reuters
7 Best Weight Loss Drug Stocks to Buy in 2025 | Investing | U.S. News - U.S News & World Report Money
Q1 Earnings Estimate for WSP Global Issued By Raymond James - Defense World
Brokerages Set TWFG, Inc. (NASDAQ:TWFG) Target Price at $31.86 - Defense World
adidas AG (OTCMKTS:ADDYY) Sees Large Growth in Short Interest - Defense World
ACS, Actividades de Construcción y Servicios, S.A. (OTCMKTS:ACSAY) Short Interest Up 104.9% in February - Defense World
Acorn Energy, Inc. (OTCMKTS:ACFN) Sees Large Increase in Short Interest - Defense World
Smithfield Foods, Inc’s (NASDAQ:SFD) Quiet Period Set To Expire on March 10th - Defense World
Short Interest in ANA Holdings Inc. (OTCMKTS:ALNPY) Decreases By 33.3% - Defense World
Alfa S.A.B. de C.V. (OTCMKTS:ALFFF) Short Interest Up 79.6% in February - Defense World
AIA Group Limited (OTCMKTS:AAGIY) Short Interest Update - Defense World
Aker ASA (OTCMKTS:AKAAF) Short Interest Up 61.0% in February - Defense World
Athena Gold Co. (OTCMKTS:AHNR) Sees Significant Growth in Short Interest - Defense World
Short Interest in Agricultural Bank of China Limited (OTCMKTS:ACGBF) Increases By 74.0% - Defense World
Short Interest in Alaris Equity Partners Income Trust (OTCMKTS:ADLRF) Grows By 137.9% - Defense World
AddLife AB (publ) (OTCMKTS:ADDLF) Short Interest Update - Defense World
Financial Comparison: Thomasville Bancshares (OTCMKTS:THVB) & U.S. Bancorp (NYSE:USB) - Defense World
OSI Systems (NASDAQ:OSIS) vs. Applied Optoelectronics (NASDAQ:AAOI) Critical Contrast - Defense World
Endava plc (NYSE:DAVA) Receives $39.10 Consensus Target Price from Brokerages - Defense World
Sanctuary Advisors LLC Has $782,000 Stake in Vornado Realty Trust (NYSE:VNO) - Defense World
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines - Business Wire
Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding $50 billion | Eli Lilly and Company - Eli Lilly and Company
A little-known Chinese company made a drug that beat the world’s biggest-selling medicine - CNN
BGXXBright Green Corp Latest Stock News & Market Updates - StockTitan
Drugs Made in America Acquisition Corp. Announces Advisory Team - The Manila Times
CanadaHelps Estimates $266 Million Loss for Charities Due to Canada Post Strike; Urges Canadians to Use Extended Donation Deadline to Give - The Manila Times
Drugs Made in America Acquisition Corp. Forms Advisory Team to Pursue Pharmaceutical Business Acquisitions - Nasdaq
Can This Power Team of Healthcare Veterans Reshape American Drug Manufacturing? - StockTitan
Popular cannabis brand declares Chapter 11 bankruptcy - TheStreet
Drugs Made In America Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing February 25, 2025 - The Manila Times
Drugs Made In America Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Rights, Commencing February 25, 2025 - Marketscreener.com
SPAC Alert: Key Trading Change Coming for Drugs Made In America UnitsWhat Investors Should Track - StockTitan
Drugs Made In America Acquisition Corp. Announces Trading Options for Public Offering Units Starting February 25, 2025 - Nasdaq
Mink Ventures Completes Acquisition of Warren Ni, Cu, Co Patents - The Manila Times
Drugs Made In America Acquisition Announces Closing Of Full Exercise Of IPO Over-Allotment Option - Marketscreener.com
ForexTV | Small Business Resources - ForexTV.com
Drugs Made In America Acquisition Corp. Secures Additional $30 Million in IPO as Underwriter Fully Exercises Overallotment Option - Nasdaq
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO ... - The Bakersfield Californian
Drugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment Option - TradingView
Nortech Systems (NASDAQ:NSYS) Coverage Initiated by Analysts at StockNews.com - Defense World
Drugs Made In America Acquisition Corp Stock (DMAAU) Financials Data
There is no financial data for Drugs Made In America Acquisition Corp (DMAAU). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.45%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):